immunotherapy

You have access
Efficacy of Cabozantinib in Metastatic Papillary Renal Cell Carcinoma Following Ineffective Treatment With Initial Therapy of Nivolumab and Ipilimumab
HIDEKAZU TACHIBANA, YUDAI ISHIYAMA, MAKI YOSHINO, KAORI YAMASHITA, DAISUKE TOKI and TSUNENORI KONDO

In Vivo May 2021, 35 (3) 1743-1747; DOI: https://doi.org/10.21873/invivo.12433
You have access
Granulocyte Colony-stimulating Factor Producing Oropharyngeal Squamous Cell Carcinoma
GREGORY SCHURMANN, MARTIN ZWEIFEL, ROLAND GIGER, TILMAN T. RAU, SARAH VINZENS, MATTHIAS S. DETTMER and YOJENA KURIAN

In Vivo May 2021, 35 (3) 1785-1790; DOI: https://doi.org/10.21873/invivo.12438
You have access
Long-term Response After Stopping Immunotherapy in a Patient With Metastatic Renal Cancer
BOGDAN HAINEALA, ANCA ZGURA, CAMELIA DIACONU, CLAUDIA MEHEDINTU, XENIA BACINSCHI and RODICA MARICELA ANGHEL

In Vivo May 2021, 35 (3) 1805-1810; DOI: https://doi.org/10.21873/invivo.12441
You have access
Lung Cancer, Covid-19 Infections and Chemotherapy
BOGDAN HAINEALA, ANCA ZGURA, DUMITRU CRISTINEL BADIU, LAURA ILIESCU, RODICA MARICELA ANGHEL and XENIA ELENA BACINSCHI

In Vivo May 2021, 35 (3) 1877-1880; DOI: https://doi.org/10.21873/invivo.12450
You have access
Micropapillary Bladder Cancer Metastatic to the Breast: A Case Report and Brief Literature Review
ELENA LIEVORE, LETTERIO RUNZA, MICHELE GHIDINI, BARBARA GALASSI, ANDREA GALLIOLI, CAROLINA BEBI, LUCA BOERI, CONCETTA BLUNDO, CLAUDIA FRANCESCA ROSSI, FABRIZIO LONGO, GIANCARLO ALBO, EMANUELE MONTANARI and ELISA DE LORENZIS

In Vivo January 2021, 35 (1) 453-459; DOI: https://doi.org/10.21873/invivo.12278
You have access
Using Image-guided Intensity-modulated Radiotherapy on Patients With Head and Neck Soft-tissue Sarcoma
KHALED ELSAYAD, DENISE STOCKMANN, MOHAMMED CHANNAOUI, SERGIU SCOBIOALA, ANETA GRAJDA, HENDRIK BERSSENBRÜGGE, SEBASTIAN HUSS, CHRISTOS MOUSTAKIS, UWE HAVERKAMP, JOHANNES KLEINHEINZ, GEORG LENZ, EVA WARDELMANN and HANS THEODOR EICH

In Vivo July 2019, 33 (4) 1293-1300; DOI: https://doi.org/10.21873/invivo.11602
You have access
Neutrophil–to–Lymphocyte Ratio Predicts Survival After Whole-brain Radiotherapy in Non-small Cell Lung Cancer
HIROSHI DOI, KIYOSHI NAKAMATSU, SHIMPEI ANAMI, KOHEI FUKUDA, MASAHIRO INADA, HITOSHI TATEBE, KAZUKI ISHIKAWA, SHUICHI KANAMORI, HAJIME MONZEN and YASUMASA NISHIMURA

In Vivo January 2019, 33 (1) 195-201; DOI: https://doi.org/10.21873/invivo.11459
You have access
Potential Risk Factors for Nivolumab-induced Thyroid Dysfunction
HARUHIKO YAMAZAKI, HIROYUKI IWASAKI, TOSHINARI YAMASHITA, TATSUYA YOSHIDA, NOBUYASU SUGANUMA, TAKASHI YAMANAKA, KATSUHIKO MASUDO, HIROTAKA NAKAYAMA, KAORI KOHAGURA, YASUSHI RINO and MUNETAKA MASUDA

In Vivo November 2017, 31 (6) 1225-1228;

Main menu

User menu

Search

immunotherapy